keyword
https://read.qxmd.com/read/38460271/novel-thiazolidin-4-one-benzenesulfonamide-hybrids-as-ppar%C3%AE-agonists-design-synthesis-and-in-vivo-anti-diabetic-evaluation
#21
JOURNAL ARTICLE
Islam H Ali, Rasha M Hassan, Ahmed M El Kerdawy, Mahmoud T Abo-Elfadl, Heba M I Abdallah, Francesca Sciandra, Iman A Y Ghannam
In the current study, two series of novel thiazolidin-4-one benzenesulfonamide arylidene hybrids 9a-l and 10a-f were designed, synthesized and tested in vitro for their PPARɣ agonistic activity. The phenethyl thiazolidin-4-one sulphonamide 9l showed the highest PPARɣ activation % by 41.7%. Whereas, the 3-methoxy- and 4-methyl-4-benzyloxy thiazolidin-4-one sulphonamides 9i, and 9k revealed moderate PPARɣ activation % of 31.7, and 32.8%, respectively, in addition, the 3-methoxy-3-benzyloxy thiazolidin-4-one sulphonamide 10d showed PPARɣ activation % of 33...
February 29, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38458647/glp-1-receptor-agonists-in-the-treatment-of-diabetic-non-alcoholic-steatohepatitis-patients
#22
JOURNAL ARTICLE
Ernest A Adeghate
INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disease affecting almost 30% of the world population. Approximately 25% of people with NAFLD develop nonalcoholic steatohepatitis (NASH), the fulminant version of the disease. Diabetes mellitus is present in 22.5% of people with NAFLD and 44.60% of individuals with NASH. This review was undertaken to examine the current contribution of glucagon-like peptide 1 (GLP-1) receptor agonists to the pharmacotherapy of diabetic nonalcoholic steatohepatitis...
March 8, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38452432/comparative-effects-of-glucose-lowering-agents-on-endothelial-function-and-arterial-stiffness-in-patients-with-type-2-diabetes-a-network-meta-analysis
#23
JOURNAL ARTICLE
Hayeon Kim, Cheol Ung Choi, Kiyon Rhew, Jiwon Park, Yejee Lim, Myeong Gyu Kim, Kyungim Kim
BACKGROUND AND AIMS: Despite accumulating evidence on the potential of glucose-lowering agents (GLAs) to prevent cardiovascular events, the comparative effects of GLAs on vascular function remain unclear. This study utilized validated indicators such as flow-mediated dilation (FMD; positive value favors) and pulse wave velocity (PWV; negative value favors) to uncover the comparative effects of GLAs on vascular function. METHODS: Randomized controlled trials (RCTs) comparing the effects of GLAs on FMD or PWV with placebo or other GLAs in patients with type 2 diabetes (T2DM) were searched through PubMed and Embase...
February 28, 2024: Atherosclerosis
https://read.qxmd.com/read/38449795/pioglitazone-a-peroxisome-proliferator%C3%A2-activated-receptor-%C3%AE-agonist-induces-cell-death-and-inhibits-the-proliferation-of-hypoxic-hepg2-cells-by-promoting-excessive-production-of-reactive-oxygen-species
#24
JOURNAL ARTICLE
Guohao Huang, Mengfan Zhang, Manzhou Wang, Wenze Xu, Xuhua Duan, Xinwei Han, Jianzhuang Ren
Hypoxia is a hallmark of solid tumors. Hypoxic cancer cells adjust their metabolic characteristics to regulate the production of cellular reactive oxygen species (ROS) and facilitate ROS-mediated metastasis. Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor that regulates the transcription of fatty acid metabolism-related genes that have a key role in the survival and proliferation function of hypoxic cancer cells. In the present study, mRNA expression in HepG2 cells under chemically induced hypoxia was assessed...
April 2024: Oncology Letters
https://read.qxmd.com/read/38444946/case-report-sustained-complete-remission-with-all-oral-meped-therapy-in-a-patient-with-hodgkin-s-disease-developing-resistance-to-pembrolizumab
#25
K Reuthner, P Aubele, K Menhart, P Rath, D C Harrer, W Herr, J Hahn, M Vogelhuber, D Heudobler, F Lueke, A Reichle, M Grube
Targeted chemotherapy and immune checkpoint inhibitors (ICPi) have expanded the spectrum of therapies for patients with relapsed/refractory (r/r) Hodgkin's disease and significantly improved the proportion of patients with long-term disease control. However, there is no standardized therapeutic option in case of further progression. Recently, we demonstrated that therapy with MEPED (metronomic chemotherapy, everolimus, pioglitazone, etoricoxib, dexamethasone) is highly effective in patients with r/r Hodgkin's disease...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38441571/enhanced-upregulation-of-sirt1-via-pioglitazone-and-ligustrazine-confers-protection-against-ethanol-induced-gastric-ulcer-in-rats
#26
JOURNAL ARTICLE
Sara A Mahmoud, Abeer Elkhoely, Elsayed K El-Sayed, Amany A E Ahmed
Gastric ulcer is a disturbing disease that impacts many people worldwide. Pioglitazone (Piog), a thiazolidinedione, and ligustrazine (Ligu), a natural component of Ligusticum chuanxiong possess gastroprotective properties. However, the underlying mechanism is not well elucidated. The present study aimed to investigate the gastroprotective effects of Piog (15 mg/kg, p.o.), Ligu (15 mg/kg, p.o.), and their combination against ethanol-induced gastric ulcer in rats. Omeprazole (10 mg/kg) was used as a standard...
March 5, 2024: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38425186/a-multicentre-double-blind-placebo-controlled-randomized-parallel-comparison-phase-3-trial-to-evaluate-the-efficacy-and-safety-of-pioglitazone-add-on-therapy-in-type-2-diabetic-patients-treated-with-metformin-and-dapagliflozin
#27
JOURNAL ARTICLE
Soo Lim, Seung-Hwan Lee, Kyung-Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won, Hyuk Sang Kwon, Mi Kyung Kim, Jung Hwan Park, In-Kyung Jeong, Sungrae Kim
AIM: To investigate the efficacy and safety of pioglitazone compared to placebo when added to metformin plus dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, for patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: In a multicentre study, with a randomized, double-blind, placebo-controlled design, 249 Korean patients with T2DM suboptimally managed on metformin and dapagliflozin were assigned to receive either pioglitazone (15 mg daily) or placebo for 24 weeks, followed by a 24-week pioglitazone extension...
February 29, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38417695/metallothionein-alleviates-glutathione-depletion-induced-oxidative-cardiomyopathy-through-cisd1-dependent-regulation-of-ferroptosis-in-murine-hearts
#28
JOURNAL ARTICLE
Feng-Juan Li, Shouzhi Fu, Hua Ye, Yi-Han Hu, Jianxin Chen, Jamie R Privratsky, Wei Yu, Feng Dong, Russel J Reiter, Maolong Dong, Jun Guo, Jun Ren
This study was designed to discern the effect of heavy scavenger metallothionein on glutathione (GSH) deprivation-evoked cardiac anomalies and mechanisms involved with an emphasis on ferroptosis. WT and cardiac metallothionein transgenic mice received GSH synthase inhibitor buthionine sulfoximine (BSO, 30 mM in drinking water) for 14 days prior to assessment of myocardial morphology and function. BSO evoked cardiac remodeling and contractile anomalies including cardiac hypertrophy, interstitial fibrosis, enlarged left ventricular chambers, deranged ejection fraction, fraction shortening, cardiomyocyte contractile capacity, intracellular Ca2+ handling, sarcoplasmic reticulum Ca2+ reuptake, loss of mitochondrial integrity (mitochondrial swelling, loss of aconitase activity), mitochondrial energy deficit, carbonyl damage, lipid peroxidation, ferroptosis and apoptosis...
February 26, 2024: American Journal of Pathology
https://read.qxmd.com/read/38413051/projection-based-two-sample-inference-for-sparsely-observed-multivariate-functional-data
#29
JOURNAL ARTICLE
Salil Koner, Sheng Luo
Modern longitudinal studies collect multiple outcomes as the primary endpoints to understand the complex dynamics of the diseases. Oftentimes, especially in clinical trials, the joint variation among the multidimensional responses plays a significant role in assessing the differential characteristics between two or more groups, rather than drawing inferences based on a single outcome. We develop a projection-based two-sample significance test to identify the population-level difference between the multivariate profiles observed under a sparse longitudinal design...
February 27, 2024: Biostatistics
https://read.qxmd.com/read/38393619/toxicometabolomics-based-cardiotoxicity-evaluation-of-thiazolidinedione-exposure-in-human-derived-cardiomyocytes
#30
JOURNAL ARTICLE
Abdullah Al Sultan, Zahra Rattray, Nicholas J W Rattray
INTRODUCTION: Thiazolidinediones (TZDs), represented by pioglitazone and rosiglitazone, are a class of cost-effective oral antidiabetic agents posing a marginal hypoglycaemia risk. Nevertheless, observations of heart failure have hindered the clinical use of both therapies. OBJECTIVE: Since the mechanism of TZD-induced heart failure remains largely uncharacterised, this study aimed to explore the as-yet-unidentified mechanisms underpinning TZD cardiotoxicity using a toxicometabolomics approach...
February 23, 2024: Metabolomics: Official Journal of the Metabolomic Society
https://read.qxmd.com/read/38389974/test-of-insulin-resistance-in-nondiabetic-and-streptozotocin-induced-diabetic-rats-using-glycosylated-hemoglobin-test-and-other-interventions
#31
JOURNAL ARTICLE
Lina AlTamimi, Zainab Z Zakaraya, Mohammad Hailat, Mousa N Ahmad, Nidal A Qinna, Mohammed F Hamad, Wael Abu Dayyih
Type 2 diabetes is common globally. Pioglitazone (PGZ) is an oral TZD antidiabetic, whereas chromium-picolinate (Cr-PL) and Cr-glucose tolerance factor (Cr-GTF) are useful type 2 diabetes mellitus (T2DM) supplements. Cr-PL/GTF antioxidants cure T2DM. They may fail in diabetes with or without insulin-sensitizing medications. It examined how Cr-PL, Cr-GTF, PGZ, and their combination affected glucose, glycosylated hemoglobin, insulin, and HOMA-IR. Sixty-three adult Sprague-Dawley rats (220-300 g) were selected, and nine rats were randomly assigned to a normal nondiabetic group...
2024: Journal of Advanced Pharmaceutical Technology & Research
https://read.qxmd.com/read/38385099/role-of-insulin-resistance-in-the-development-of-nonalcoholic-fatty-liver-disease-in-people-with-type-2-diabetes-from-bench-to-patient-care
#32
JOURNAL ARTICLE
Juan Patricio Nogueira, Kenneth Cusi
Insulin resistance is implicated in both the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and its progression from steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma, which is known to be more common in people with type 2 diabetes. This article reviews the role of insulin resistance in the metabolic dysfunction observed in obesity, type 2 diabetes, atherogenic dyslipidemia, and hypertension and how it is a driver of the natural history of NAFLD by promoting glucotoxicity and lipotoxicity...
2024: Diabetes Spectrum: a Publication of the American Diabetes Association
https://read.qxmd.com/read/38385098/pharmacological-approaches-to-nonalcoholic-fatty-liver-disease-current-and-future-therapies
#33
JOURNAL ARTICLE
Idoia Genua, Kenneth Cusi
Nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic steatohepatitis (NASH), can promote the development of cirrhosis, hepatocellular carcinoma, cardiovascular disease, and type 2 diabetes. Similarly, type 2 diabetes confers the greatest risk for the development of NASH, especially when associated with obesity. Although lifestyle changes are critical to success, early implementation of pharmacological treatments for obesity and type 2 diabetes are essential to treat NASH and avoid disease progression...
2024: Diabetes Spectrum: a Publication of the American Diabetes Association
https://read.qxmd.com/read/38381204/vimentin-protein-is-a-factor-for-decreasing-breast-cancer-cell-proliferation-co-culture-with-human-bone-marrow-derived-mesenchymal-stem-cells-pre-treated-with-thiazolidinedione-solutions
#34
JOURNAL ARTICLE
Lim Shern Kwok, Shim Siang Yian, Layla Qasim Ismael, Yvonne Tee Get Bee, Gam Lay Harn, Khoo Boon Yin
BACKGROUND: Our previous study investigated the levels of soluble growth factors in the conditioned media of bone marrow-derived mesenchymal stem cells (BMSCs) pre-treated with thiazolidinedione solutions. The present study aimed to investigate the complex intracellular proteins extracted from BMSCs pre-treated with pioglitazone and/or rosiglitazone using proteomics. METHODS: The proliferative effect of the identified protein on MCF-7 cells that interacted non-adhesively with BMSCs pre-treated with pioglitazone and/or rosiglitazone was evaluated using cell culture inserts and conditioned media...
February 21, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38378472/pparg-activation-promotes-the-proliferation-of-colorectal-cancer-cell-lines-and-enhances-the-antiproliferative-effect-of-5-fluorouracil
#35
JOURNAL ARTICLE
Leah Schöckel, Christine Woischke, Sai Agash Surendran, Marlies Michl, Tobias Schiergens, Andreas Hölscher, Florian Glass, Peter Kreissl, Frederick Klauschen, Michael Günther, Steffen Ormanns, Jens Neumann
BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPARG) is a member of the nuclear receptor family. It is involved in the regulation of adipogenesis, lipid metabolism, insulin sensitivity, vascular homeostasis and inflammation. In addition, PPARG agonists, known as thiazolidinediones, are well established in the treatment of type 2 diabetes mellitus. PPARGs role in cancer is a matter of debate, as pro- and anti-tumour properties have been described in various tumour entities...
February 20, 2024: BMC Cancer
https://read.qxmd.com/read/38376305/the-antidiabetic-drug-pioglitazone-ameliorates-betel-nut-induced-carcinogenesis-in-mice-by-restoring-normal-lipid-metabolism-reducing-oxidative-stress-and-inducing-apoptosis
#36
JOURNAL ARTICLE
Moumita Nath, Kasturi Bhattacharjee, Yashmin Choudhury
CONTEXT: Oral administration (2 mg mL-1) of aqueous extract of betel nut (AEBN) for 24 weeks induced oncogenic alterations in the liver of female Swiss Albino mice concomitant with aberrant lipid metabolism, overactivation of Akt/mTOR signaling, and loss of apoptosis. AIM: This study was designed to investigate the potential of repurposing the antidiabetic drug pioglitazone for alleviating AEBN-induced carcinogenesis. METHODS: Sera of animals were evaluated for lipid profile and free fatty acid levels...
October 1, 2023: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38374053/metformin-versus-metformin-plus-pioglitazone-on-gonadal-and-metabolic-profiles-in-normal-weight-women-with-polycystic-ovary-syndrome-a-single-center-open-labeled-prospective-randomized-controlled-trial
#37
RANDOMIZED CONTROLLED TRIAL
Han Zhao, Jiaqi Zhang, Chuan Xing, Xiangyi Cheng, Bing He
OBJECTIVE: To investigate the effects of metformin (MET) monotherapy and pioglitazone plus MET (PIOMET) therapy on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome (PCOS). METHODS: Sixty normal-weight women with PCOS were recruited between January and September 2022 at the Shengjing Hospital of China Medical University. They were randomly assigned to the MET or PIOMET groups for 12 weeks of MET monotherapy or PIOMET therapy. Anthropometric measurements, menstrual cycle changes, gonadal profiles, and the oral glucose insulin-releasing test (OGIRT) were performed at baseline and after the 12-week treatment...
February 19, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38373652/anti-steatotic-effects-of-ppar-alpha-and-gamma-involve-gut-liver-axis-modulation-in-high-fat-diet-fed-mice
#38
JOURNAL ARTICLE
Isabela Macedo Lopes Vasques-Monteiro, Aline Fernandes-da-Silva, Carolline Santos Miranda, Flavia Maria Silva-Veiga, Julio Beltrame Daleprane, Vanessa Souza-Mello
AIM: To evaluate the effects of PPARα and PPARγ activation (alone or in combination) on the gut-liver axis, emphasizing the integrity of the intestinal barrier and hepatic steatosis in mice fed a high saturated fat diet. METHODS: Male C57BL/6J were fed a control diet (C) or a high-fat diet (HF) for ten weeks. Then, a four-week treatment started: HF-α (WY14643), HF-γ (low-dose pioglitazone), and HF-αγ (combination). RESULTS: The HF caused overweight, insulin resistance, impaired gut-liver axis, and marked hepatic steatosis...
February 17, 2024: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/38364741/tumor-cell-derived-osteopontin-and-prostaglandin-e2-synergistically-promote-the-expansion-of-myeloid-derived-suppressor-cells-during-the-tumor-immune-escape-phase
#39
JOURNAL ARTICLE
Doste R Mamand, Safa Bazaz, Dara K Mohammad, Osama Saher, Oscar P B Wiklander, Behnam Sadeghi, Moustapha Hassan, Samir El-Andaloussi, Manuchehr Abedi-Valugerdi
The immune escape stage in cancer immunoediting is a pivotal feature, transitioning immune-controlled tumor dormancy to progression, and augmenting invasion and metastasis. Tumors employ diverse mechanisms for immune escape, with generating immunosuppressive cells from skewed hematopoiesis being a crucial mechanism. This led us to suggest that tumor cells with immune escape properties produce factors that induce dysregulations in hematopoiesis. In support of this suggestion, this study found that mice bearing advanced-stage tumors exhibited dysregulated hematopoiesis characterized by the development of splenomegaly, anemia, extramedullary hematopoiesis, production of immunosuppressive mediators, and expanded medullary myelopoiesis...
February 15, 2024: International Immunopharmacology
https://read.qxmd.com/read/38361536/regulation-of-the-immune-microenvironment-by-pioglitazone-loaded-polylactic-glycolic-acid-nanosphere-composite-scaffolds-to-promote-vascularization-and-bone-regeneration
#40
JOURNAL ARTICLE
Shijie Fan, Yadong Tan, Xiuchen Yuan, Chun Liu, Xiaoyu Wu, Ting Dai, Su Ni, Jiafeng Wang, Yiping Weng, Hongbin Zhao
Osteogenesis is caused by multiple factors, and the inflammatory response, osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), regeneration of blood vessels, and other factors must be considered in bone tissue engineering. To effectively repair bone defect, it is important to decrease excessive inflammation, enhance the differentiation of mesenchymal stem cells into osteoblasts, and stimulate angiogenesis. Herein, nano-attapulgite (ATP), polyvinyl alcohol (PVA), and gelatin (GEL) scaffolds were produced using 3D printing technology and pioglitazone (PIO)-containing polylactic acid-glycolic acid (PLGA) nanospheres were added...
2024: Journal of Tissue Engineering
keyword
keyword
42459
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.